You are viewing: Rest Of Europe Sleep Apnea Oral Appliances Market analysis

The Rest Of Europe Sleep Apnea Oral Appliances Market was valued at $37.3 Million in 2025 and projected to reach to $57.5 Million by 2030, representing a compound annual growth rate of 9.1%. Rest Of Europe's sleep apnea oral appliances market demonstrates robust growth potential, expanding from USD 37.3 million in 2025 to USD 57.5 million by 2030 at a 9.1% CAGR.

Rest Of Europe Sleep Apnea Oral Appliances Market (2025-2030) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

Rest Of Europe Sleep Apnea Oral Appliances Market Trends and Insights

  • Rest Of Europe represents a significant opportunity within the broader European sleep apnea treatment landscape, driven by increasing awareness of oral appliance therapy as a non-invasive alternative to continuous positive airway pressure (CPAP) devices.
  • The region's growth trajectory reflects rising diagnosis rates, improved reimbursement policies, and growing patient preference for mandibular advancement devices and tongue retention mouthpieces. Rest Of Europe's market expansion is supported by demographic shifts, including an aging population with higher sleep apnea prevalence, and enhanced healthcare infrastructure across smaller European nations.
  • Between 2025 and 2030, Rest Of Europe is expected to capture growing market share as dental professionals and sleep specialists increasingly recommend oral appliances for mild-to-moderate obstructive sleep apnea cases.
  • The region's 9.1% compound annual growth rate underscores strong demand momentum and the therapeutic shift toward patient-centric, comfortable treatment options in Rest Of Europe..

Key Market Statistics

  • CAGR (2025-2030) 9.1% CAGR
  • Market Size, 2025 ~USD 37.3 Million
  • Forecast, 2030 ~USD 57.5 Million
  • Country Rest Of Europe

Rest Of Europe Sleep Apnea Oral Appliances Market Overview

Market Valuation Growth :

Rest Of Europe's sleep apnea oral appliances market is valued at USD 37.3 million in 2025, with a projected CAGR of 9.1% through 2030, reaching USD 57.5 million by forecast end.

Non-Invasive Treatment Adoption :

Increasing patient preference for oral appliance therapy as a non-invasive alternative to CPAP devices is driving market expansion across Rest Of Europe, particularly in countries with advanced healthcare infrastructure.

Regional Healthcare Awareness :

Growing awareness campaigns and clinical endorsements for sleep apnea diagnosis and treatment are accelerating oral appliance adoption rates throughout Rest Of Europe's healthcare systems.

Competitive Market Positioning :

Rest Of Europe represents a significant opportunity within the broader European sleep apnea treatment landscape, with distinct market dynamics separate from major Western European markets.

Rest Of Europe Sleep Apnea Oral Appliances Market Dynamics

  • This expansion is fueled by rising sleep apnea prevalence, improved diagnostic capabilities, and growing patient awareness of oral appliance therapy benefits.
  • Healthcare providers increasingly recognize oral appliances as effective alternatives to traditional CPAP therapy, particularly for patients with compliance challenges. The market outlook remains positive as healthcare systems across Rest Of Europe prioritize sleep disorder management and invest in advanced treatment modalities.
  • Reimbursement improvements, clinical guideline updates, and manufacturer expansion strategies are expected to further accelerate market penetration.
  • Regional variations in healthcare spending and regulatory frameworks will create differentiated growth opportunities for market participants targeting specific Rest Of Europe segments..

Related Ecosystem

Dental Devices

Top Technologies
  • Dental Implants
  • Dental Bone Grafts
  • Dental Crowns
  • Dental Prosthetics
  • Zirconium Implants
Top Companies
  • DENTSPLY SIRONA Inc.
  • Henry Schein, Inc.
  • KAVO KERR GROUP
  • PLANMECA GROUP
  • Patterson Companies, Inc.

    Medical Devices

    Top Technologies
    • Polymerase Chain Reaction (PCR)
    • Magnetic Resonance Imaging (MRI)
    • Disposable Autoinjectors
    • Pulse Oximeters
    • Blood Pressure Monitors
    Top Companies
    • Medtronic plc
    • Abbott Laboratories
    • Stryker Corporation
    • Becton, Dickinson and Company
    • JOHNSON & JOHNSON

      Key Takeaways

      • Rest Of Europe's sleep apnea oral appliances market will grow from USD 37.3 million (2025) to USD 57.5 million (2030), representing a 9.1% CAGR.
      • Rest Of Europe is shifting toward oral appliance therapy as a preferred alternative to CPAP, driven by patient comfort and compliance improvements.
      • Aging demographics and rising sleep apnea diagnosis rates in Rest Of Europe are key growth catalysts for the oral appliances segment.
      • Rest Of Europe's expanding reimbursement coverage and dental professional adoption are accelerating market penetration through 2030.

      Sleep Apnea Oral Appliances Market Report Scope

      Report Metric Details
      Base Year 2025
      Fastest Growing Segment ONLINE PHARMACIES (Distribution Channel)
      Forecast Period 2025–2030
      Growth Rate CAGR of 9.8% from 2025 to 2030
      Largest Segment MANDIBULAR ADVANCEMENT DEVICES (Product)
      Market Size Base Year (Billions) ~USD 0.5 (2025)
      Revenue Forecast (Billions) ~USD 0.8 (2030)
      Segments Covered Product, Type, Purchase Type, Gender, Age Group, Distribution Channel, End User

      Rest Of Europe Sleep Apnea Oral Appliances Market Report Segmentation

      7 segment dimensions are covered across the global market.

      By Product

      • Daytime-Nighttime Appliances
      • Mandibular Advancement Devices
      • Tongue-Retaining Devices

      By Type

      • Custom-Made Mads
      • Ready-Made Mads

      By Purchase Type

      • Online Otc Oral Appliances
      • Physician-Prescribed/Customized Oral Appliances

      By Gender

      • Female Patients
      • Male Patients

      By Age Group

      • Above 60 Years
      • Below 40 Years
      • Between 40-60 Years

      By Distribution Channel

      • Hospital Pharmacies
      • Hospital Pharmacies & Dental Clinics
      • Online Pharmacies
      • Retail Pharmacies

      By End User

      • Dental Clinics
      • Home Care Settings/Individuals
      • Hospitals

      Target Audience

      • Medical Device Manufacturers : Manufacturers of oral appliances and sleep apnea devices need Rest Of Europe-specific market data to identify growth opportunities, optimize product positioning, and develop region-tailored commercialization strategies.
      • Healthcare Investors & PE Firms : Investment professionals require detailed Rest Of Europe market analysis to evaluate acquisition targets, assess portfolio company growth potential, and identify emerging opportunities in the sleep apnea treatment sector.
      • Dental & Sleep Medicine Practitioners : Clinicians and dental sleep medicine specialists need market insights to understand treatment adoption trends, patient demand patterns, and reimbursement landscape changes affecting their practice growth in Rest Of Europe.
      • Healthcare Consultants & Advisors : Strategy consultants supporting healthcare clients require Rest Of Europe-specific market intelligence to develop business plans, competitive analyses, and market entry strategies for sleep apnea treatment providers.
      • Healthcare System Administrators : Hospital networks and healthcare system leaders need Rest Of Europe market data to inform procurement decisions, budget allocation for sleep disorder programs, and clinical pathway development for oral appliance therapy.

      Key Companies in the Rest Of Europe Sleep Apnea Oral Appliances Market

      CompanyHQOwnershipStrongest segments
      LIVANOVA PLCUnited KingdomPublic CompanyMandibular Advancement Devices (MAD),Tongue-Retaining Devices (TRD),Implantable Sleep Apnea Neuromodulation (aura6000),
      COLGATEUnited StatesPublic CompanyMandibular Advancement Devices (MAD),Tongue-Retaining Devices (TRD),Physician-prescribed (all products),
      SOMNOMEDAustraliaPublic CompanyMandibular Advancement Devices (SomnoDent Avant, Classic, Flex, Fusion and related MADs),Tongue-Retaining Devices (TRD) and other oral sleep devices,Adjacencies (SomMorning Repositioner, SomnoBrux splints, SomTabs and accessories),
      RESMEDUnited StatesPublic CompanyMandibular Advancement Devices (MAD),Tongue-Retaining Devices (TRD),Physician-prescribed (all oral appliances),
      PROSOMNUS SLEEP TECHNOLOGIESUnited StatesPrivate CompanyMandibular Advancement Devices (MAD),Tongue-Retaining Devices (TRD),Other custom intraoral OSA devices / accessories,
      VIVOS THERAPEUTICS, INC.United StatesPublic CompanyMandibular Advancement Devices (MAD),Tongue-Retaining Devices (TRD),Physician-prescribed programs and services (screening, home sleep test, treatment planning),
      ORAVANOSAMandibular Advancement Devices (MAD),Tongue-Retaining Devices (TRD),Physician-prescribed channel,

      LIVANOVA PLC

      LivaNova PLC is a United Kingdom-based medical device company founded in 2015 with 3,300 employees. Operating as a public company, it develops innovative healthcare solutions.

      COLGATE

      Colgate is a United States-based consumer goods company founded in 1806 with 33,600 employees. As a public company, it is a global leader in oral care and personal hygiene products.

      SOMNOMED

      SomnoMed is an Australian medical device company founded in 1987 with 300 employees. Operating as a public company, it specializes in sleep and respiratory solutions.

      RESMED

      ResMed is a United States-based medical device and software company founded in 1989 with 10,600 employees. As a public company, it focuses on digital health and cloud-connected medical devices.

      PROSOMNUS SLEEP TECHNOLOGIES

      ProSomnus Sleep Technologies is a United States-based private company founded in 2016 with 136 employees. It develops innovative solutions for sleep and airway management.

      VIVOS THERAPEUTICS, INC.

      Vivos Therapeutics, Inc. is a United States-based public company founded in 2016 with 270 employees. It develops medical devices and therapeutics for sleep apnea and airway management.

      ORAVANOSA

      Insufficient data available for company description.

      Reasons to Buy this Report

      • Market-Specific Growth Projections : Access detailed forecasts showing Rest Of Europe's market expansion from USD 37.3M to USD 57.5M (2030), enabling precise investment and expansion planning tailored to this specific regional segment.
      • Competitive Landscape Intelligence : Understand Rest Of Europe's unique competitive dynamics, market positioning strategies, and differentiation opportunities separate from broader European market trends and major Western European competitors.
      • Regional Regulatory & Reimbursement Insights : Gain critical intelligence on Rest Of Europe's healthcare reimbursement policies, regulatory requirements, and clinical guideline adoption rates affecting oral appliance market penetration and pricing strategies.
      • Customer Adoption & Awareness Trends : Identify Rest Of Europe-specific patient awareness levels, treatment preference shifts toward non-invasive therapies, and healthcare provider adoption patterns driving market demand and growth opportunities.
      • Strategic Market Entry & Expansion : Develop targeted go-to-market strategies for Rest Of Europe with actionable insights on market gaps, distribution channels, partnership opportunities, and growth acceleration pathways specific to this region.

      Frequently asked questions

      What is the market size of sleep apnea oral appliances in Rest Of Europe?

      Rest Of Europe's sleep apnea oral appliances market was valued at USD 37.3 million in 2025 and is forecast to reach USD 57.5 million by 2030.

      What is the growth rate for oral appliances in Rest Of Europe?

      Rest Of Europe's market is growing at a compound annual growth rate (CAGR) of 9.1% from 2025 to 2030.

      Why is Rest Of Europe's oral appliances market expanding?

      Rest Of Europe's market expansion is driven by rising sleep apnea diagnosis rates, aging populations, improved reimbursement policies, and growing patient preference for non-invasive oral appliance therapy over CPAP devices.

      Which oral appliance types are most popular in Rest Of Europe?

      Mandibular advancement devices (MADs) and tongue retention mouthpieces are the most widely adopted oral appliance types in Rest Of Europe for treating mild-to-moderate obstructive sleep apnea.

      How does Rest Of Europe's market compare to other European regions?

      Rest Of Europe represents a distinct market segment within Europe with its own growth dynamics, reimbursement structures, and healthcare infrastructure that differentiate it from major European markets.

      RESEARCH METHODOLOGY

      This study involved the extensive use of both primary and secondary sources. The research process involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, competitive landscape, fundamental market dynamics, and key player strategies.

      Secondary Research

      The secondary research process involves the widespread use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B Hoovers), white papers, annual reports, investor presentations, SEC filings of companies and publications from government sources [such as National Institutes of Health (NIH), US FDA, US Census Bureau, World Health Organization (WHO), Global Burden of Disease Study, and Centers for Medicare and Medicaid Services (CMS) were referred to identify and collect information for the global sleep apnea oral appliances market study. It was used to gather vital information about key players, classify and segment the market according to industry trends, down to the most detailed level, and highlight key developments related to market and technological perspectives. A database of the key industry leaders was also prepared using secondary research.

      Primary Research

      In the primary research process, we interviewed various supply and demand sources to gather qualitative and quantitative information for this report. The supply-side sources included industry experts such as CEOs, vice presidents, marketing and sales directors, technology and innovation directors, and other key executives from prominent companies and organizations within the sleep apnea oral appliances market. On the demand side, we gathered insights from sleep clinics, dental clinics, hospitals, and academic institutions. This primary research was conducted to validate market segmentation, identify key players in the industry, and gain insights into important industry trends and market dynamics.

      A breakdown of the primary respondents is provided below:

      Sleep Apnea Oral Appliances Market

      Note 1: C-level primaries include CEOs, CFOs, COOs, and VPs.

      Note 2: Others include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.

      Note 3: Companies are classified into tiers based on their total revenue. As of 2024, Tier 1 = >USD 10.00 billion, Tier 2 = USD 1.00 billion to USD 10.00 billion, and Tier 3 = < USD 1.00 billion.

      Source: MarketsandMarkets Analysis

      To know about the assumptions considered for the study, download the pdf brochure

      Market Size Estimation

      For the global market value, annual revenues were calculated based on the revenue mapping of major product manufacturers and OEMs active in the global sleep apnea oral appliances market. All the leading service providers were identified at the global/country/regional level. Revenue mapping for the respective business segments/subsegments was conducted for the major players. Also, the global sleep apnea oral appliances market was split into various segments and subsegments based on the following:

      • List of primary players operating in the products market at the regional and/or country level
      • Product mapping of sleep apnea oral appliance providers at the regional and/or country level
      • Mapping of annual revenue generated by listed major players from sleep apnea oral appliances (or the nearest reported business unit/product category)
      • Extrapolation of the revenue mapping of the listed major players to derive the global market value of the respective segments/subsegments
      • Summation of the market value of all segments/subsegments to arrive at the global sleep apnea oral appliances market

      The above data was consolidated and added with detailed inputs and analysis from MarketsandMarkets and presented in this report.

      Market Size Estimation (Bottom-up approach & Top-down approach)

      Sleep Apnea Oral Appliances Market

      Data Triangulation

      After arriving at the overall size of the global sleep apnea oral appliances market through the methodology mentioned above, this market was split into several segments and subsegments. Where applicable, the data triangulation and market breakdown procedures were employed to complete the overall market engineering process and arrive at the exact market value data for the key segments and subsegments. The extrapolated market data was triangulated by studying various macro indicators and regional trends from both demand- and supply-side participants.

      Market Definition

      Sleep apnea is a common sleep disorder that usually goes undiagnosed but has severe and life-threatening effects. The most common type of sleep apnea is obstructive sleep apnea. Due to patient non-compliance with positive airway pressure (PAP) devices, oral appliances are gaining popularity in treating sleep apnea. Oral appliance therapy (OAT) treats snoring and obstructive sleep apnea (OSA) patients. OAT can be an effective treatment for patients who prefer oral appliances over continuous positive airway pressure (CPAP) or those unable to tolerate CPAP.

      Stakeholders

      • Manufacturers & distributors of sleep apnea oral appliances
      • Hospitals
      • Dental clinics
      • Healthcare corporations
      • Medical service providers
      • Ambulatory surgery centers
      • Appliance suppliers
      • Consulting firms
      • Government associations
      • Venture capitalists & investors 

      Report Objectives

      • To define, describe, segment, and forecast the global sleep apnea oral appliances market by product, gender, purchase type, age group, distribution channel, end user, and region
      • To provide detailed information regarding the major factors influencing market growth (such as drivers, restraints, opportunities, challenges, and trends)
      • To analyze the micromarkets with respect to individual growth trends, prospects, and contributions to the overall sleep apnea oral appliances market
      • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
      • To forecast the size of the market segments concerning six regions: North America, Europe, the Asia Pacific, Latin America, the Middle East & Africa, and the GCC Countries
      • To profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies
      • To benchmark players within the market using the proprietary Company Evaluation Matrix framework, which analyzes market players on various parameters within the broad categories of business and product excellence

       

      Get the Full Sleep Apnea Oral Appliances Market Report

      Full forecast, segment splits, and company analysis for all Sleep Apnea Oral Appliances Market.

      Need a Tailored Report?

      Customize this report to your needs

      Get 10% FREE Customization

      Customize This Report
      Fact checked
      DMCA.com Protection Status